These findings suggest that PRKAG1 may reshape the HCC immune microenvironment by differentially regulating the infiltration of specific immune cell subsets (e.g., memory B cells, M0 macrophages) and through synergistic effects with MALAT1, thereby influencing tumor immune escape and clinical outcomes. Here, PRKAG1 is linked to hepatocellular carcinoma.